REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Aburaihan Pharmaceutical Company Public Joint Stock (Iran)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Aburaihan Pharmaceutical Company Public Joint Stock Profile Updated: July 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Aburaihan Pharmaceutical Co has been a manufacturer of human and animal medicines. The company's products are available in Iran and several other countries in Asia and Africa.

Headquarters
Tehranpars Cross Road, Khoshvaght Street, No.1
Tehran; Tehran; Postal Code: 1654613111

Contact Details: Purchase the Aburaihan Pharmaceutical Company Public Joint Stock report to view the information.

Website: http://www.aburaihan.com

Basic Information
Total Employees:
Purchase the Aburaihan Pharmaceutical Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Aburaihan Pharmaceutical Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Aburaihan Pharmaceutical Company Public Joint Stock report to view the information.
Incorporation Date:
1965
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
35.4%
Purchase this report to view the information.
0.944%
Purchase this report to view the information.
0.626%
Purchase this report to view the information.
0.413%
Purchase this report to view the information.
0.392%
Company Performance
Financial values in the chart are available after Aburaihan Pharmaceutical Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
92.87%▲
Total operating revenue
92.87%▲
Operating profit (EBIT)
49.62%▲
EBITDA
51.26%▲
Net Profit (Loss) for the Period
37.16%▲
Total assets
8.66%▲
Total equity
-50.8%▼
Operating Profit Margin (ROS)
-11.06%▼
Net Profit Margin
-8.82%▼
Return on Equity (ROE)
23.2%▲
Debt to Equity Ratio
115.45%▲
Quick Ratio
-0.25%▼
Cash Ratio
-0.03%▼

Similar companies

Daroupakhsh Holding Company Public Joint Stock
 
Barkat Pharmaceutical Group Company Public Joint Stock
Pars Darou Company Public Joint Stock
 
Dr. Abidi Pharmaceuticals Company Public Joint Stock
Sobhan Pharmaceutical Group Company Public Joint Stock
 
Tehran Chemie Pharmaceutical Company Public Joint Stock (تهران كيمي للدواء المساهمة العامة (Tehran))
Darou Pakhsh Pharma Chemicals Company Public Joint Stock
 
Jaber Ebne Hayyan Pharmaceutical Company Public Joint Stock
Amin Pharmaceutical Company Public Joint Stock
 
Alhavi Pharmaceutical Company Public Joint Stock
Loghman Pharmaceutical & Hygienic Company Public Joint Stock
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo